receives

JZP458 receives CHMP recommendation for approval in ALL, lymphoblastic lymphoma

JZP458 receives CHMP recommendation for approval in ALL, lymphoblastic lymphoma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of JZP458, a recombinant erwinia asparaginase or chrysantaspase, for use in combination with multiagent chemotherapy for the treatment of adult and pediatric patients 1 month of age and older with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) who have …

JZP458 receives CHMP recommendation for approval in ALL, lymphoblastic lymphoma Read More »

Kapil Lakhotia

Drugmaker receives $4 million in federal cash as London’s life sciences sector grows

Links to the Breadcrumb Trail News Local news A London drugmaker to add cutting-edge technology and scale up production for the Canadian market with federal help. Published July 12, 2023 1 minute read London Economic Development Corp. chief executive Kapil Lakhotia, left, and Mayor Josh Morgan are shown in this LFP file photo. Article content …

Drugmaker receives $4 million in federal cash as London’s life sciences sector grows Read More »

Scroll to Top